Co-Authors
This is a "connection" page, showing publications co-authored by HELEN PIWNICA-WORMS and GLORIA ECHEVERRIA.
Connection Strength
2.771
-
Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer. NPJ Breast Cancer. 2023 Jan 10; 9(1):2.
Score: 0.872
-
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state. Sci Transl Med. 2019 04 17; 11(488).
Score: 0.673
-
High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer. Nat Commun. 2018 11 29; 9(1):5079.
Score: 0.656
-
An annotated biobank of triple negative breast cancer patient-derived xenografts featuring treatment-na?ve and longitudinal samples throughout neoadjuvant chemotherapy. bioRxiv. 2024 Nov 28.
Score: 0.248
-
Pharmacologic profiling of patient-derived xenograft models of primary treatment-na?ve triple-negative breast cancer. Sci Rep. 2020 10 21; 10(1):17899.
Score: 0.187
-
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer. Breast Cancer Res. 2016 Jan 27; 18(1):13.
Score: 0.135